Terrie Curran's Net Worth
$10.1 Million
Who is Terrie Curran?
Terrie Curran has an estimated net worth of $10.1 Million. This is based on reported shares across multiple companies, which include Myovant Sciences Ltd., Phathom Pharmaceuticals, Inc., Arcutis Biotherapeutics, Inc., and CELGENE CORP /DE/.
SEC CIK
Terrie Curran's CIK is 0001690298
Past Insider Trading and Trends
2019 was Terrie Curran's most active year for acquiring shares with 9 total transactions. Terrie Curran's most active month to acquire stocks was the month of April. 2019 was Terrie Curran's most active year for disposing of shares, totalling 34 transactions. Terrie Curran's most active month to dispose stocks was the month of October. 2021 saw Terrie Curran paying a total of $488,204.05 for 324,358 shares, this is the most they've acquired in one year. In 2021 Terrie Curran cashed out on 129,742 shares for a total of $1,836,627.91, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Myovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.67K |
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
∞
| 9.86K |
—
|
—
| 9.86K |
Oct 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 4
|
—
|
0
|
$16.61 | -$86,960.50 |
0
|
Scheduled
|
Sep 9
| ||
Form 4
|
—
|
0
|
$16.34 | -$842,727.85 |
0
|
Scheduled
|
Sep 1 - Sep 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Phathom Pharmaceuticals, Inc. (PHAT) Snapshot price: $17.55
President and Chief Executive
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.22% | -33.85K |
$11.72 | -$396,698.56 | 377.73K |
Jul 15
| |||
Form 4
| -3.94% | -16.85K |
$9.11 | -$153,512.61 | 410.78K |
Mar 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
| +9.62% | 37.5K |
—
|
—
| 427.17K |
Nov 1
| |||
Form 4
| +105.45% | 200K |
—
|
—
| 389.67K |
Jul 14
| |||
Form 4
| +7.37% | 12.92K |
$7.82 | $101,025.29 | 188.29K |
Apr 6
| |||
Form 4
| -0.81% | -1.44K |
$8.54 | -$12,265.02 | 175.37K |
Scheduled
|
Mar 1
| ||
Form 4
| +107.70% | 91.68K |
$8.20 | -$47,729.29 | 176.81K |
Jan 19 - Jan 20
| |||
Form 4
| -1.79% | -1.53K |
$9.60 | -$14,649.60 | 83.72K |
Nov 21
| |||
Form 4
| +9.65% | 7.5K |
—
|
—
| 85.25K |
Sep 1
| |||
Form 4
| +18.58% | 12K |
—
|
—
| 76.59K |
May 19
| |||
Form 4
| +46.49% | 20.5K |
$7.41 | $151,835.30 | 64.59K |
May 13
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +1,449.91% | 41.25K |
—
|
—
| 44.09K |
Jan 19
| |||
Form 4
|
—
|
0
|
$25.14 | -$418,735.51 |
0
|
Scheduled
|
Mar 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $10.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +116.71% | 10.14K |
—
|
—
| 18.83K |
Jun 14
| |||
Form 4
| +101.46% | 4.38K |
—
|
—
| 8.69K |
May 31
| |||
Form 4
|
∞
| 4.31K |
—
|
—
| 4.31K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CELGENE CORP /DE/ No price found
PRES., GLBL INFLAM. AND IMMUN.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 4
| -100.00% | -4.64K |
—
|
—
|
0
|
Nov 20
| |||
Form 4
| +100.14% | 2.16K |
$108.03 | -$121,317.69 | 4.31K |
Oct 31
| |||
Form 4
| -76.04% | -6.84K |
$78.30 | -$851,658.78 | 2.15K |
Sep 18
| |||
Form 4
| +13.55% | 1.07K |
$95.21 | -$46,652.90 | 8.99K |
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +19.08% | 1.27K |
$68.20 | -$83,954.20 | 7.92K |
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
| +32.83% | 1.64K |
$86.89 | -$74,377.84 | 6.65K |
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| +27.57% | 1.08K |
$107.06 | -$73,121.98 | 5.01K |
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
| -30.56% | -1.73K |
$143.89 | -$248,498.03 | 3.92K |
Scheduled
|
Sep 25
| ||
Form 4
| +20.00% | 942 |
$135.18 | -$75,430.44 | 5.65K |
Jul 31 - Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||